TAVR VARC-3 Classification Calculator

Clinical calculation support · Verify results before clinical use

Patient Profile

Enter baseline clinical variables to create a concise profile for documentation. No VARC-3 risk score is calculated.

Profile helper
Enter age in completed years (18–120).
Enter the reported STS-PROM estimate (0–100%). This is not a VARC-3 score.
Enter LVEF as a percentage (0–100%).
Important clinical clarificationVARC-3 is a consensus framework that standardizes clinical endpoint definitions for aortic valve research. The original template's additive points and Low / Intermediate / High Risk cutoffs are not established by the cited VARC-3 consensus and should not be interpreted as a validated VARC-3 classification or used to guide treatment.

Patient profile summary

Age
—
STS-PROM
—
NYHA class
—
LVEF
—
Coronary artery disease
—

About VARC-3

The Valve Academic Research Consortium 3 (VARC-3) consensus updates standardized endpoint definitions for transcatheter and surgical aortic valve clinical research. It supports consistent event reporting and adjudication rather than providing a single additive baseline risk score from age, STS-PROM, NYHA class, LVEF, and coronary artery disease.

Examples of VARC-3 endpoint domains

DomainExamples
Clinical eventsMortality, stroke, hospitalization, bleeding, myocardial infarction
Procedure-related complicationsVascular/access-related and cardiac structural complications, conduction disturbances, acute kidney injury
Valve-related outcomesBioprosthetic valve dysfunction or failure, valve thrombosis, paravalvular regurgitation
Composite endpointsTechnical success, device success, early safety, clinical efficacy, and long-term valve-related clinical efficacy

Use of the patient profile

The entered variables can help document baseline status, but any operative-risk estimate should come from a validated model used within its intended population and context. Interpret the clinical profile alongside a comprehensive heart-team assessment.

Reference

VARC-3 Writing Committee; Généreux P, Piazza N, et al.Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical Research. J Am Coll Cardiol. 2021;77(21):2717–2746.doi:10.1016/j.jacc.2021.02.038
VARC-3 Writing Committee; Généreux P, Piazza N, et al.Valve Academic Research Consortium 3: updated endpoint definitions for aortic valve clinical research. Eur Heart J. 2021;42(19):1825–1857.doi:10.1093/eurheartj/ehaa799

These consensus publications support the endpoint framework and the clarification that VARC-3 is not the additive score implemented in the former template.

Clinical disclaimer: This helper summarizes entered baseline data and does not calculate procedural risk, predict outcomes, establish TAVR eligibility, or replace validated risk assessment and heart-team decision-making. Verify all entered values against the medical record.